Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors
Not Applicable
Completed
- Conditions
- FatigueSleep DisturbanceCircadian Dysregulation
- Interventions
- Device: Morning bright light therapyDevice: Dim light
- Registration Number
- NCT02954809
- Lead Sponsor
- State University of New York at Buffalo
- Brief Summary
The purpose of this study is to determine the feasibility of a morning bright light therapy intervention for fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
- Detailed Description
A randomized controlled trial to test the effects of morning bright light therapy on fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
- Stage I-III Non-small cell lung cancer survivors
- Must be at >6-weeks and < 3 years post-surgical resection
- Must have diagnosis fatigue and/or sleep disturbances
Exclusion Criteria
- Individuals clinically unstable.
- Mania, Bipolar disease or seizure disorder
- Macular degeneration or glaucoma.
- Currently receiving chemotherapy or radiation.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Experimental Morning bright light therapy Exposure to morning bright light therapy delivered with Green-Blue Re-Timer glasses for 30 minutes in the morning during one week. Attention Control Dim light Exposure to dim light delivered with Red-Yellow Re-Timer glasses for 30 minutes in the morning during one week.
- Primary Outcome Measures
Name Time Method Study Completion Baseline The percentage of participants recruited that completed the study
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
SUNY University at Buffalo
🇺🇸Buffalo, New York, United States